| Factor Information | |
|---|---|
| Data ID | 1877 |
| Factor | HFSS with arrhythmia requiring treatment |
| Description | Lower mean HFSS was observed for patients who arrhythmia requiring treatment (10.0 ± 0.70 vs. 10.5 ± 0.89, P = .005) |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | Lower mean HFSS |
| p Value | <0.01 |
| OR | 3.6 |
| Conclusion | Although a low HFSS was significantly associated with outcomes, it did not adequately risk stratify adults with CHD, whose heterogeneous pathophysiology differs from that of the acquired heart failure population. Further studies are warranted to provide a more accurate prognosis. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 560 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF/RV/EA/other |
| Reference | |
|---|---|
| PMID | 25358483 |
| Year | 2015 |
| Title | Predicting Outcomes Using the Heart Failure Survival Score in Adults with Moderate or Complex Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | N/A | |
| Region | New York & Boston, USA | |
| Method | N/A | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | arrhythmia requiring treatment (HFSS<10.4)(Treatment) | without arrhythmia requiring treatment (HFSS≥10.4)(Control) |
| Number | 86 | 83 |
| Age | 32.6 ± 12.2 years | 34.7 ± 12.9 years |
| Gender (Male: Female) | 40:46 | 40:43 |
| Marker Level | HFSS: 10.0 ± 0.70 | HFSS: 10.5 ± 0.89 |
